GASTRIC CANCER ADENOCARCINOMA METASTATIC
Clinical trials for GASTRIC CANCER ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new GASTRIC CANCER ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for GASTRIC CANCER ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stomach cancer: first human trial of BDC-4182 begins
Disease control Recruiting nowThis early-phase study tests a new drug called BDC-4182 in people with advanced stomach or gastroesophageal cancer that has spread or cannot be removed. The main goals are to check safety and find the right dose, while also seeing if the drug can shrink tumors or slow the disease…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New drug cocktail targets stomach cancer with fluid buildup
Disease control Recruiting nowThis study is for people with stomach cancer that has spread to the lining of the belly and causes fluid buildup (ascites). It tests a combination of three drugs: lenvatinib, nivolumab, and chemotherapy. The goal is to see if this combination can help control the cancer and impro…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Promising new combo offers hope for stomach cancer patients who fail immunotherapy
Disease control Recruiting nowThis study is for people with advanced stomach cancer that has spread and no longer responds to first-line immunotherapy. It tests a new combination of three drugs: a targeted therapy (fruquintinib), a chemotherapy (nab-paclitaxel), and a novel immunotherapy (iparomlimab and tuvo…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Dai, Guanghai • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug cocktail targets stomach cancer protein to extend lives
Disease control Recruiting nowThis study tests whether adding the drug Zolbetuximab to standard chemotherapy can help people with a specific type of advanced stomach or gastroesophageal cancer live longer. It is for patients whose tumors have a protein called CLDN18.2 and who have already tried one prior trea…
Matched conditions: GASTRIC CANCER ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated May 19, 2026 11:46 UTC